Clinical Trial Endpoints in Breast Cancer

Feb 12, 2017 by in ONCOLOGY Comments Off on Clinical Trial Endpoints in Breast Cancer

Fig. 27.1 Comparison of overall survival and surrogate endpoints Disease-Free Survival (DFS) Disease-free survival (DFS) is defined as the time from randomization until recurrence of tumor or death from any…

read more

Breast Cancer Stem Cells and Cellomics

Feb 12, 2017 by in ONCOLOGY Comments Off on Breast Cancer Stem Cells and Cellomics

Gene Description Function(s) Signature type and importance Annexin A5 (ANXA5) Gene encodes indirect inhibitor of the thromboplastin-specific complex involved in the blood coagulation cascade Calcium ion binding, calcium-dependent phospholipid binding,…

read more

Breast Cancer Therapy–Classical Therapy, Drug Targets, and Targeted Therapy

Feb 12, 2017 by in ONCOLOGY Comments Off on Breast Cancer Therapy–Classical Therapy, Drug Targets, and Targeted Therapy

Drug class Agents Alkylating agents Cyclophosphamide Antimetabolites 5-Fluouracil (5-FU), methotrexate, capecitabine, gemcitabine Platinum salts Cisplatin, carboplatin, oxaliplatin Anthracyclines Daunorubicin, doxorubicin, idarubicin, epirubicin, mitoxantrone Topoisomerase I inhibitors Irinotecan Topoisomerase II inhibitors…

read more

Breast Cancer Genomics

Feb 12, 2017 by in ONCOLOGY Comments Off on Breast Cancer Genomics

Recognized gene/region Position Mapped by Allele incidence Recognized/feasible role BRCA1 17q21 Linkage Rare DNA repair/genome stability BRCA2 13q13.1 Linkage Rare Recombinational repair TP53 17p13.1 Linkage Rare Li–Fraumeni syndrome, apoptosis ATM…

read more
Get Clinical Tree app for offline access